TABLE 1.

Information of HCC patients in TCGA and the ICGC.

Clinical characteristics		Total	%	Clinical characteristics		Total	%
TCGA		370				370
Survival status	Survival	244	65.95	T	T1	181	48.92
	Death	126	34.05		T2	93	25.14
Age	≤65 years	232	62.7		T3	80	21.62
	>65 years	138	37.3		T4	13	3.51
Grade	G1	55	14.86	M	M0	266	71.89
	G2	177	47.84		M1	4	1.08
	G3	121	32.7		MX	100	27.03
	G4	12	3.24	N	N0	252	68.11
Stage	I	171	46.22		N1	4	1.08
	II	85	22.97		NX	113	30.54
	III	85	22.97	Gender	Male	249	67.3
	IV	5	1.35		Female	121	32.7
ICGC		232				232
Survival status	Survival	189	81.47	Stage	I	36	15.52
	Death	43	18.53		II	106	45.69
Age	≤65 years	90	38.79		III	71	30.6
	>65 years	142	61.21		IV	19	8.19
Gender	Male	171	73.71	Prior malignancy	No	202	87.07
	Female	61	26.29		Yes	30	12.93

HCC, hepatocellular carcinoma; ICGC, International Cancer Genome Consortium; TCGA, The Cancer Genome Atlas.